Evidence map›Paper›PMID 42472674›Full record

ArticleDiabetes, obesity & metabolism2026

Age of Type 1 Diabetes Onset and Dementia Risk: A Swedish Nationwide, Register-Based Cohort Study.

Milena Jancev, Björn Eliasson, Geert Jan Biessels, J Hans DeVries, Erik H Serné, Frank L J Visseren, Araz Rawshani, Aidin Rawshani, Tali Cukierman-Yaffe, Naveed Sattar and 2 more

Abstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Milena JancevDepartment of Vascular Medicine and Endocrinology, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID 0000-0002-5193-8459
Björn EliassonDepartment of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Geert Jan BiesselsDepartment of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht, the Netherlands.
J Hans DeVriesDepartment of Internal Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Erik H SernéDepartment of Internal Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Frank L J VisserenDepartment of Vascular Medicine and Endocrinology, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID 0000-0003-3951-5223
Araz RawshaniDepartement of Clinical & Molecular Medicine, Institute of Medicine, Gothenburg, Sweden.
Aidin RawshaniDepartement of Clinical & Molecular Medicine, Institute of Medicine, Gothenburg, Sweden.
Tali Cukierman-YaffeDivision of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Epidemiology Department, School of Public Health, Gray Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.ORCID 0000-0003-1289-5633
Naveed SattarSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.ORCID 0000-0002-1604-2593
Hertzel C GersteinPopulation Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.ORCID 0000-0001-8072-2836
Thomas T van SlotenDepartment of Vascular Medicine and Endocrinology, University Medical Center Utrecht, Utrecht, the Netherlands.

Funding

Diabetes Fonds 2021.81.004Diabetes Fonds 2024.35.001European Foundation for the Study of Diabetes
6 · The paper itself

Abstract

aimsIndividuals with Type 1 diabetes are at a higher risk of dementia compared to individuals without diabetes. Younger age at Type 1 diabetes onset has been linked to an increased risk of cardiovascular disease and higher mortality. This study aimed to determine whether younger age at Type 1 diabetes onset was also associated with all-cause dementia. MATERIALS AND

methodsThis nationwide prospective cohort study used data from individuals with Type 1 diabetes from the Swedish National Diabetes Register. All-cause dementia, including Alzheimer's disease, vascular dementia and non-Alzheimer's-non-vascular dementia, was prospectively ascertained as ICD-10 codes. Age at onset was stratified into < 10 years, 10-17 years and 18-30 years. The 18-30 years group was used as the reference group for all analyses. Cox regression modelling with age as the time-axis, from age at diabetes onset, was deployed to investigate dementia risk.

resultsOf 43 440 included individuals (mean age 33.0 (SD 14.0) years; 44% female), Type 1 diabetes developed before age 10 in 11 776 individuals (27%), between age 10 and 17 in 15 846 (36%) and between 18 and 30 (reference group) in 15 818 (36%). During a median 29.3 [17.6-43.7] years follow-up, 530 (1.2%) developed all-cause dementia. Compared to the reference group, all-cause dementia risk was increased in individuals aged < 10 years at onset (HR 1.37 [95% CI 1.08-1.73]), but not in individuals aged 10-17 years at onset (HR 1.04 [95% CI 0.85-1.26]) (fully adjusted model).

conclusionsType 1 diabetes onset before age 10 is associated with an increased risk of all-cause dementia compared to onset between ages 18 and 30.

Indexed as

DementiaDiabetes Mellitus, Type 1AdolescentAdultAge of OnsetChildCohort StudiesFemaleHumansMaleMiddle AgedProspective StudiesRegistriesRisk FactorsSwedenYoung Adultcohort studyelderlyobservational studyType 1 diabetes

Identifiers

PMID42472674
PMCPMC13538778

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.